Biogen (BIIB) FY 2025 10-K Key Highlights (Filed 2026) | Explained for Beginners
🌍 What the Company Does Biogen (BIIB) is a global biotechnology company focused on medicines for neurological, neurodegenerative, rare, and immune-related diseases. Its key areas include multiple sclerosis, Alzheimer’s disease, rare diseases, spinal muscular atrophy, and immunology. In plain English, Biogen is trying to move from older multiple sclerosis products toward a broader portfolio built […]
Biogen (BIIB) FY 2025 10-K Key Highlights (Filed 2026) | Explained for Beginners Read More »
